Cost-effectiveness of biennial screening for diabetes related retinopathy in people with type 1 and type 2 diabetes compared to annual screening
ConclusionsBase case and sensitivity analyses indicate biennial screening to be cost-effective for T2DM irrespective of HbA1c and duration of diabetes. However, the uncertainty around the DCER indicates that annual screening should be maintained for those with T1DM especially when the HbA1c exceeds 80 mmol/mol (9.5%) and duration of diabetes is greater than 12 years.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research
More News: Diabetes | Diabetes Type 1 | Diabetes Type 2 | Economics | Endocrinology | Health Management | Primary Care | Study | Wales Health